Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
The critical role of the class III histone deacetylase SIRT1 in cancer Liu T; Liu PY; Marshall GMCancer Res 2009[Mar]; 69 (5): 1702-5Gene expression and deacetylase activity of the class III histone deacetylase SIRT1 are up-regulated in cancer cells due to oncogene overexpression or loss of function of tumor suppressor genes. SIRT1 induces histone deacetylation and methylation, promoter CpG island methylation, transcriptional repression, and deacetylation of tumor suppressor proteins. SIRT1 may play a critical role in tumor initiation, progression, and drug resistance by blocking senescence and apoptosis, and promoting cell growth and angiogenesis. SIRT1 inhibitors have shown promising anticancer effects in animal models of cancer. Further screening for more potent SIRT1 inhibitors may lead to compounds suitable for clinical trials in patients.|Acetylation[MESH]|Animals[MESH]|Apoptosis[MESH]|Cell Proliferation[MESH]|CpG Islands[MESH]|DNA Methylation[MESH]|Enzyme Inhibitors/therapeutic use[MESH]|Genes, Tumor Suppressor[MESH]|Histones/metabolism[MESH]|Humans[MESH]|Methylation[MESH]|Neoplasms/drug therapy/*enzymology[MESH]|Oncogenes[MESH]|RNA, Messenger/analysis[MESH]|Sirtuin 1[MESH]|Sirtuins/antagonists & inhibitors/genetics/*physiology[MESH] |